| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.75▲ | 1.72▲ | 1.71▲ | 1.99▼ | 2.65▼ |
| MA10 | 1.74▲ | 1.70▲ | 1.67▲ | 2.44▼ | 2.58▼ |
| MA20 | 1.73▲ | 1.67▲ | 1.69▲ | 2.68▼ | 2.37▼ |
| MA50 | 1.70▲ | 1.77▼ | 2.28▼ | 2.53▼ | 2.86▼ |
| MA100 | 1.67▲ | 2.32▼ | 2.59▼ | 2.35▼ | 3.10▼ |
| MA200 | 1.69▲ | 2.63▼ | 2.70▼ | 2.71▼ | 2.39▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▲ | 0.026▲ | 0.050▲ | -0.169▼ | 0.038▲ |
| RSI | 75.445▲ | 53.576▲ | 38.858▼ | 30.097▼ | 39.358▼ |
| STOCH | 59.722 | 85.477▲ | 77.304 | 23.571 | 62.493 |
| WILL %R | -16.667▲ | -2.941▲ | -31.250 | -88.667▼ | -90.173▼ |
| CCI | 130.769▲ | 140.000▲ | 114.474▲ | -129.154▼ | -78.239 |
|
Sunday, February 01, 2026 08:28 AM
Cardiff Oncology saw its shares nosedive following the departure of its CEO and CFO, plus questions about some Phase II data for its candidate onvansertib in first-line RAS-mutated metastatic ...
|
|
Tuesday, January 27, 2026 02:24 PM
Cardiff Oncology Inc. welcomed Mani Mohindru as interim CEO and simultaneously provided what the company dubbed a “positive” but stock-denting clinical update. The firm rolled out data from the ...
|
|
Cardiff Oncology Taps Interim CEO, Picks 30mg Onvansertib Regimen for 2026 Registrational mCRC Study
Tuesday, January 27, 2026 08:16 AM
Cardiff Oncology (NASDAQ:CRDF) outlined a management transition and provided an updated clinical data readout for onvansertib during a company conference call focused on its ongoing Phase II CRDF-004 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/01/26 | 1.66 | 1.76 | 1.58 | 1.75 | 2,188,700 |
| 29/01/26 | 1.69 | 1.83 | 1.61 | 1.62 | 3,369,700 |
| 28/01/26 | 1.99 | 2.02 | 1.62 | 1.62 | 7,110,835 |
| 27/01/26 | 2.062 | 2.10 | 1.85 | 2.00 | 11,150,464 |
| 26/01/26 | 2.88 | 2.96 | 2.80 | 2.94 | 617,000 |
| 23/01/26 | 2.95 | 3.05 | 2.88 | 2.90 | 402,322 |
| 22/01/26 | 2.89 | 3.01 | 2.86 | 2.97 | 641,200 |
| 21/01/26 | 2.84 | 2.90 | 2.78 | 2.89 | 348,400 |
| 20/01/26 | 2.77 | 2.85 | 2.72 | 2.81 | 530,000 |
| 16/01/26 | 2.80 | 3.02 | 2.78 | 2.88 | 771,400 |
|
|
||||
|
|
||||
|
|